763 programming-"https:"-"FEMTO-ST"-"UCL"-"https:"-"https:"-"https:"-"https:" positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Germany
- Austria
- United Kingdom
- Denmark
- Spain
- France
- Canada
- United Arab Emirates
- Australia
- Belgium
- India
- South Africa
- Mexico
- Sweden
- Singapore
- Switzerland
- Vietnam
- Turkey
- Ireland
- Malaysia
- Netherlands
- Norway
- Taiwan
- Algeria
- Argentina
- Finland
- Hong Kong
- New Zealand
- South Korea
- Worldwide
- 21 more »
- « less
-
Program
-
Field
-
, particularly in the compulsory and elective subjects of the curriculum in the field of Roman law - either in the German-language diploma programme or in the English-language programme in International Law
-
status and have privileges to apply for external grants to expand their research program. The Fellows will have a strong support network and opportunities to build a highly interdisciplinary and
-
program at the interface of drug delivery, biomaterials, and cancer biology. The successful candidate will play a key role in developing next-generation therapeutic platforms, including lipid nanoparticles
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
-malignant blood diseases, such as sickle cell disease, bone marrow failure syndromes, and myeloproliferative disorders. This premier NHLBI-sponsored T32 training program leverages the exceptional research
-
Postdoctoral Research Associate- Training in the Design & Development of Infectious Disease Therapeu
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in infectious disease therapeutics. This NIH sponsored training program has been designed to leverage the outstanding
-
students each year. About the IdEx Advanced Research Program As part of its commitment to excellence and international prominence, Université Côte d’Azur is launching the 2026 call for applications
-
working with systems biology, drug-gene interactions, and network analysis. Projects will focus on advancing cutting-edge drug discovery programs for childhood catastrophic diseases using the latest
-
natural and AI-designed protein domains, along with an engineered fusogenic protein. The technology has been recognized with the m4 Award, the GO-Bio next program, and is currently under revision in a top
-
of acute myeloid leukemia (AML), understanding how the rewiring of chromatin landscapes contributes to the development and maintenance of malignant programs. The final aim of our studies is to translate our
-
developmental programming, and oncogenic transformation using genome editing methods with multi-omic approaches. The successful candidate will lead projects aimed at dissecting the developmental programming